Insulet Corporation (PODD)
USD 256.8
(-4.58%)
USD 256.8
(-4.58%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 323.6 Million USD | 502.74% |
| 2022 | 109.5 Million USD | -70.59% |
| 2021 | 139.6 Million USD | 126.46% |
| 2020 | 110.3 Million USD | 9.6% |
| 2019 | 77 Million USD | 82.33% |
| 2018 | 49.77 Million USD | 471.23% |
| 2017 | 6.5 Million USD | 25.23% |
| 2016 | 1.27 Million USD | 69.92% |
| 2015 | -36.27 Million USD | -167.06% |
| 2014 | -24.44 Million USD | 57.79% |
| 2013 | -16.17 Million USD | 19.0% |
| 2012 | -24.83 Million USD | -28.97% |
| 2011 | -35.82 Million USD | 6.31% |
| 2010 | -33.38 Million USD | 49.85% |
| 2009 | -53.89 Million USD | 20.0% |
| 2008 | -81.17 Million USD | -55.16% |
| 2007 | -48.92 Million USD | -53.47% |
| 2006 | -32 Million USD | -53.73% |
| 2005 | -20.26 Million USD | -46.56% |
| 2004 | -13.49 Million USD | -15.12% |
| 2003 | -12.01 Million USD | 5.19% |
| 2002 | -12.67 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 75.7 Million USD | -18.25% |
| 2024 Q2 | 73.8 Million USD | -21.75% |
| 2023 FY | - USD | 502.74% |
| 2023 Q4 | 30.2 Million USD | -45.59% |
| 2023 Q3 | 55.5 Million USD | 79.61% |
| 2023 Q1 | 27.5 Million USD | 10.0% |
| 2023 Q2 | 30.9 Million USD | 12.36% |
| 2022 Q1 | 38.2 Million USD | -22.52% |
| 2022 Q2 | -27.8 Million USD | -172.77% |
| 2022 Q3 | 1.1 Million USD | 103.96% |
| 2022 Q4 | 25 Million USD | 2172.73% |
| 2022 FY | - USD | -70.59% |
| 2021 Q2 | 28.1 Million USD | 105.11% |
| 2021 FY | - USD | 126.46% |
| 2021 Q4 | 49.3 Million USD | 49.39% |
| 2021 Q1 | 13.7 Million USD | 328.33% |
| 2021 Q3 | 33 Million USD | 17.44% |
| 2020 Q3 | 24.8 Million USD | -12.98% |
| 2020 Q2 | 28.5 Million USD | 280.0% |
| 2020 Q1 | 7.5 Million USD | -58.79% |
| 2020 FY | - USD | 9.6% |
| 2020 Q4 | -6 Million USD | -124.19% |
| 2019 FY | - USD | 82.33% |
| 2019 Q1 | 16.45 Million USD | 1.36% |
| 2019 Q2 | 7.6 Million USD | -53.79% |
| 2019 Q3 | 17 Million USD | 123.65% |
| 2019 Q4 | 18.2 Million USD | 7.03% |
| 2018 Q1 | 5.2 Million USD | 777.6% |
| 2018 Q2 | 9.62 Million USD | 84.86% |
| 2018 Q3 | 12.82 Million USD | 33.28% |
| 2018 FY | - USD | 471.23% |
| 2018 Q4 | 16.23 Million USD | 26.6% |
| 2017 Q1 | -1.55 Million USD | 59.4% |
| 2017 FY | - USD | 25.23% |
| 2017 Q4 | -768 Thousand USD | -137.52% |
| 2017 Q3 | 2.04 Million USD | 160.96% |
| 2017 Q2 | -3.35 Million USD | -116.51% |
| 2016 Q2 | -1.15 Million USD | 84.61% |
| 2016 Q1 | -7.52 Million USD | 68.68% |
| 2016 Q4 | -3.82 Million USD | -161.04% |
| 2016 FY | - USD | 69.92% |
| 2016 Q3 | 6.25 Million USD | 639.95% |
| 2015 Q3 | -15.69 Million USD | -27.42% |
| 2015 Q1 | -5.15 Million USD | -128.65% |
| 2015 FY | - USD | -167.06% |
| 2015 Q4 | -24.04 Million USD | -53.15% |
| 2015 Q2 | -12.32 Million USD | -138.94% |
| 2014 FY | - USD | 57.79% |
| 2014 Q4 | -2.25 Million USD | 21.59% |
| 2014 Q1 | 1.48 Million USD | 618.45% |
| 2014 Q2 | -3.11 Million USD | -310.2% |
| 2014 Q3 | -2.87 Million USD | 7.55% |
| 2013 Q2 | -5.82 Million USD | 6.19% |
| 2013 FY | - USD | 19.0% |
| 2013 Q4 | 206 Thousand USD | 101.45% |
| 2013 Q3 | -14.19 Million USD | -143.73% |
| 2013 Q1 | -6.2 Million USD | -1.97% |
| 2012 Q4 | -6.08 Million USD | -33.67% |
| 2012 Q1 | -8.02 Million USD | -19.27% |
| 2012 Q3 | -4.55 Million USD | 41.93% |
| 2012 Q2 | -7.84 Million USD | 2.27% |
| 2012 FY | - USD | -28.97% |
| 2011 Q2 | -10.4 Million USD | -70.33% |
| 2011 Q4 | -6.72 Million USD | -12.6% |
| 2011 Q3 | -5.97 Million USD | 42.6% |
| 2011 Q1 | -6.11 Million USD | -46.77% |
| 2011 FY | - USD | 6.31% |
| 2010 Q1 | -10.73 Million USD | 0.1% |
| 2010 Q3 | -7.02 Million USD | 29.01% |
| 2010 Q2 | -9.9 Million USD | 7.74% |
| 2010 Q4 | -4.16 Million USD | 40.77% |
| 2010 FY | - USD | 49.85% |
| 2009 Q4 | -10.74 Million USD | 11.3% |
| 2009 FY | - USD | 20.0% |
| 2009 Q3 | -12.11 Million USD | 19.91% |
| 2009 Q2 | -15.12 Million USD | 6.47% |
| 2009 Q1 | -16.16 Million USD | 36.96% |
| 2008 Q4 | -25.64 Million USD | -42.06% |
| 2008 FY | - USD | -55.16% |
| 2008 Q1 | -18.59 Million USD | -26.81% |
| 2008 Q2 | -20.07 Million USD | -7.95% |
| 2008 Q3 | -18.05 Million USD | 10.07% |
| 2007 Q1 | -9.8 Million USD | -16.26% |
| 2007 Q4 | -14.66 Million USD | -20.58% |
| 2007 FY | - USD | -53.47% |
| 2007 Q3 | -12.16 Million USD | -8.72% |
| 2007 Q2 | -11.18 Million USD | -14.06% |
| 2006 FY | - USD | -53.73% |
| 2006 Q2 | 674 Thousand USD | 0.0% |
| 2006 Q1 | 674 Thousand USD | 110.35% |
| 2006 Q3 | -8.48 Million USD | -1358.46% |
| 2006 Q4 | -8.43 Million USD | 0.54% |
| 2005 Q3 | -5.04 Million USD | 0.0% |
| 2005 Q1 | -5.04 Million USD | 0.0% |
| 2005 Q2 | -5.04 Million USD | 0.0% |
| 2005 FY | - USD | -46.56% |
| 2005 Q4 | -6.51 Million USD | -29.22% |
| 2004 FY | - USD | -15.12% |
| 2003 FY | - USD | 5.19% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 2499.348% |
| Cerus Corporation | -26.53 Million USD | 1319.475% |
| OrthoPediatrics Corp. | -8.38 Million USD | 3961.114% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 3183.523% |
| Talis Biomedical Corporation | -66.04 Million USD | 589.969% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 2040.63% |
| Inogen, Inc. | -45.67 Million USD | 808.422% |
| Spectral AI, Inc. | -12.26 Million USD | 2739.047% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 778.506% |
| CVRx, Inc. | -38.73 Million USD | 935.506% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 9272.336% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 2772.834% |
| Orthofix Medical Inc. | -86.98 Million USD | 472.018% |
| Venus Concept Inc. | -26.11 Million USD | 1339.23% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 750.178% |
| Bioventus Inc. | -23.07 Million USD | 1502.687% |
| BrainsWay Ltd. | -2.31 Million USD | 14102.596% |
| Envoy Medical, Inc. | -18.23 Million USD | 1874.317% |
| electroCore, Inc. | -17.76 Million USD | 1922.072% |
| IceCure Medical Ltd | -15.25 Million USD | 2221.55% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 750.439% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 2019.826% |
| MaxCyte, Inc. | -44.12 Million USD | 833.321% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 2852.641% |
| Nexalin Technology, Inc. | -5.69 Million USD | 5785.13% |
| PAVmed Inc | -75.74 Million USD | 527.24% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 701.957% |
| RxSight, Inc. | -41.03 Million USD | 888.557% |
| Sight Sciences, Inc. | -49.41 Million USD | 754.862% |
| SI-BONE, Inc. | -34.44 Million USD | 1039.441% |
| TELA Bio, Inc. | -40.63 Million USD | 896.397% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 655.079% |
| Treace Medical Concepts, Inc. | -39 Million USD | 929.573% |
| LivaNova PLC | 39.01 Million USD | -729.403% |
| 908 Devices Inc. | -34.02 Million USD | 1051.065% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 392.607% |
| Nemaura Medical Inc. | -7.28 Million USD | 4540.75% |
| NeuroPace, Inc. | -22.83 Million USD | 1517.185% |
| LENSAR, Inc. | -8.71 Million USD | 3813.564% |
| Apyx Medical Corporation | -18.11 Million USD | 1886.661% |
| Cutera, Inc. | -136.56 Million USD | 336.964% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 9673.964% |
| BioSig Technologies, Inc. | -28.15 Million USD | 1249.515% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -12761.685% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 1641.76% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 15.634% |
| Axonics, Inc. | 7.77 Million USD | -4062.058% |
| Outset Medical, Inc. | -153.78 Million USD | 310.418% |
| IRIDEX Corporation | -7.44 Million USD | 4444.791% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 429.884% |
| IRadimed Corporation | 20.8 Million USD | -1455.722% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 4113.893% |
| INVO Bioscience, Inc. | -6.88 Million USD | 4803.473% |
| Telesis Bio, Inc. | -40.49 Million USD | 899.15% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -782.297% |
| Varex Imaging Corporation | 67.2 Million USD | -381.548% |
| Quipt Home Medical Corp. | 44.07 Million USD | -634.27% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 3077.001% |
| Pulmonx Corporation | -55.09 Million USD | 687.381% |
| Dynatronics Corporation | -976 Thousand USD | 33255.466% |
| Modular Medical, Inc. | -17.1 Million USD | 1992.066% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 2334.035% |
| Semler Scientific, Inc. | 23.58 Million USD | -1271.826% |
| InMode Ltd. | 196.28 Million USD | -64.864% |
| Bruker Corporation | 599 Million USD | 45.977% |
| Cytosorbents Corporation | -28.81 Million USD | 1223.189% |
| DexCom, Inc. | 916.7 Million USD | 64.699% |
| Align Technology, Inc. | 799.03 Million USD | 59.501% |
| Viveve Medical, Inc. | -20.61 Million USD | 1669.579% |
| ZimVie Inc. | 91.07 Million USD | -255.319% |
| Movano Inc. | -29.12 Million USD | 1211.073% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 7441.199% |
| Nexalin Technology, Inc. | -5.69 Million USD | 5785.13% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 9272.336% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 266.241% |
| Profound Medical Corp. | -27.12 Million USD | 1293.063% |
| enVVeno Medical Corporation | -25.01 Million USD | 1393.469% |
| Surmodics, Inc. | 1.18 Million USD | -27139.057% |
| iCAD, Inc. | -6.56 Million USD | 5029.17% |
| Nuwellis, Inc. | -16.35 Million USD | 2078.479% |
| Biotricity, Inc. | -8.82 Million USD | 3765.498% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 434.084% |
| Aethlon Medical, Inc. | -11.84 Million USD | 2831.005% |
| InspireMD, Inc. | -20.91 Million USD | 1647.511% |
| PAVmed Inc. | -75.74 Million USD | 527.24% |
| BIOLASE, Inc. | -15.13 Million USD | 2237.526% |
| Beyond Air, Inc. | -59.03 Million USD | 648.187% |
| FONAR Corporation | 28.25 Million USD | -1045.423% |
| AxoGen, Inc. | -13.32 Million USD | 2527.971% |
| Vivani Medical, Inc. | -26.6 Million USD | 1316.176% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -1218.61% |
| Inari Medical, Inc. | 7.11 Million USD | -4449.417% |
| UFP Technologies, Inc. | 72.74 Million USD | -344.854% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 9657.603% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 5356.664% |
| Tenon Medical, Inc. | -15.52 Million USD | 2183.977% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 2219.743% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 880.215% |
| AdaptHealth Corp. | -171.09 Million USD | 289.139% |
| Sintx Technologies, Inc. | -6.6 Million USD | 5003.03% |
| NanoVibronix, Inc. | -3.43 Million USD | 9520.67% |
| Quanterix Corporation | -38.08 Million USD | 949.611% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 3077.001% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -1078566.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 216.704% |
| TransMedics Group, Inc. | -7.6 Million USD | 4356.215% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 1586.791% |
| NeuroMetrix, Inc. | -7.09 Million USD | 4660.438% |
| Hyperfine, Inc. | -47.06 Million USD | 787.618% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 654.993% |
| Biomerica, Inc. | -5.99 Million USD | 5499.633% |
| Bone Biologics Corporation | 479.57 Thousand USD | -67376.834% |
| AVITA Medical, Inc. | -39.56 Million USD | 917.838% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 3627.771% |
| Silk Road Medical, Inc | -45.08 Million USD | 817.835% |